Joan found that the frequency of the rs2302427 (D185H) allele of the EZH2 gene was 3.7% and 5.2% in the case and control groups, respectively, and that the EZH2 heterozygous genotype significantly reduced the risk of prostate cancer (OR = 0. The gene discussed is EZH2; the disease is prostate carcinoma.